Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease.

We have applied immunohistology and in situ hybridization to bronchial biopsies of patients with chronic obstructive pulmonary disease (COPD) to examine neutrophil recruitment and to determine neutrophil chemoattractant and CXC receptor (CXCR) 1 and CXCR2 gene expression associated with acute severe exacerbations. Cells were counted in endobronchial biopsies of (1) patients with COPD intubated for exacerbations (E-COPD; n = 15), (2) those with COPD in a stable phase of their disease (S-COPD; n = 7), and (3) nonsmoker surgical control subjects intubated for a nonrespiratory surgical procedure (n = 15). In comparison with the nonrespiratory surgical procedure and S-COPD groups, neutrophilia and gene expression for epithelial-derived neutrophil attractant-78 (CXCL5), interleukin-8 (CXCL8), CXCR1, and CXCR2 were each upregulated in the E-COPD group (p < 0.01); compared with the S-COPD group, by 97-, 6-, 6-, 3-, and 7-fold, respectively (p < 0.01). In E-COPD, there was a significant positive association between the number of neutrophils and CXCR2 mRNA-positive cells (r = 0.79; p < 0.01) but not between the number of neutrophils and CXCR1 mRNA-positive cells. At the time of sampling of the mucosa, there was no association between neutrophil number and either the length of intubation or viral infection. Thus, in COPD, in addition to CXCL8 and CXCR1, CXCL5 and CXCR2 appear to play important roles in the airway neutrophilia characteristic of severe exacerbations.

[1]  Chemokines and their receptors in asthma and chronic obstructive pulmonary disease , 2003, Current opinion in pulmonary medicine.

[2]  R. Strieter Interleukin-8: a very important chemokine of the human airway epithelium. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[3]  T. Seemungal,et al.  Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease , 2002, Thorax.

[4]  S. Storey,et al.  Expression of fatty acid binding proteins inhibits lipid accumulation and alters toxicity in L cell fibroblasts. , 2002, American journal of physiology. Cell physiology.

[5]  R. Pauwels,et al.  Global Initiative for Chronic Obstructive Lung Diseases (GOLD). , 2002, Pulmonary pharmacology & therapeutics.

[6]  B. Beghé,et al.  Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema. , 2002, American journal of respiratory and critical care medicine.

[7]  W. Bailey,et al.  Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution , 2023, Medical science monitor : international medical journal of experimental and clinical research.

[8]  L. Fabbri,et al.  Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.

[9]  M. Burdick,et al.  ENA-78 is an important angiogenic factor in idiopathic pulmonary fibrosis. , 2001, American journal of respiratory and critical care medicine.

[10]  E. Mason,et al.  Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. , 2001, American journal of respiratory and critical care medicine.

[11]  P. Jeffery Remodeling in asthma and chronic obstructive lung disease. , 2001, American journal of respiratory and critical care medicine.

[12]  T. Seemungal,et al.  Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[13]  L. Fabbri,et al.  Exacerbations of Bronchitis: bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractants. , 2001, American journal of respiratory and critical care medicine.

[14]  C. Owen Chemokine receptors in airway disease: which receptors to target? , 2001, Pulmonary pharmacology & therapeutics.

[15]  L. Fabbri,et al.  Cellular and structural bases of chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[16]  K. Wright,et al.  Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[17]  J. Wedzicha Mechanisms of exacerbations. , 2001, Novartis Foundation symposium.

[18]  P. Jeffery,et al.  Comparison of the structural and inflammatory features of COPD and asthma. Giles F. Filley Lecture. , 2000, Chest.

[19]  T. Seemungal,et al.  Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[20]  P. Hiemstra,et al.  Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD , 2000, The Journal of pathology.

[21]  M. Matthay,et al.  Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: Clinical and biologic significance. , 2000, American journal of respiratory and critical care medicine.

[22]  R. Stockley,et al.  Inflammation--role of the neutrophil and the eosinophil. , 2000, Seminars in respiratory infections.

[23]  A. Sousa,et al.  Subepithelial immunopathology of the large airways in smokers with and without chronic obstructive pulmonary disease. , 2000, The European respiratory journal.

[24]  A. Zlotnik,et al.  Chemokines: a new classification system and their role in immunity. , 2000, Immunity.

[25]  V. Peinado,et al.  Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[26]  F. Saulnier,et al.  Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. , 1999, American journal of respiratory and critical care medicine.

[27]  J. Zimmerman,et al.  Respiratory tract viral infections in inner-city asthmatic adults. , 1998, Archives of internal medicine.

[28]  L. Fabbri,et al.  Severity of airflow limitation is associated with severity of airway inflammation in smokers. , 1998, American journal of respiratory and critical care medicine.

[29]  M. Iannettoni,et al.  Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. , 1998, The Journal of clinical investigation.

[30]  F. Saulnier,et al.  Bronchial neutrophilia in patients with noninfectious status asthmaticus. , 1998, American journal of respiratory and critical care medicine.

[31]  P. Proost,et al.  Interleukin-8 and other CXC chemokines , 1998 .

[32]  D. Wilkinson In situ hybridization: a practical approach , 1998 .

[33]  J. Baier,et al.  Induction of neutrophil chemoattractant cytokines by Mycoplasma hominis in alveolar type II cells , 1997 .

[34]  S. Wenzel,et al.  Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. , 1997, American journal of respiratory and critical care medicine.

[35]  G. Zimmerman,et al.  Human endothelial cells synthesize ENA-78: relationship to IL-8 and to signaling of PMN adhesion. , 1997, American journal of respiratory cell and molecular biology.

[36]  B. Balbi,et al.  Increased bronchoalveolar granulocytes and granulocyte/macrophage colony-stimulating factor during exacerbations of chronic bronchitis. , 1997, The European respiratory journal.

[37]  P. Herdewijn,et al.  Characterization of synthetic human granulocyte chemotactic protein 2: usage of chemokine receptors CXCR1 and CXCR2 and in vivo inflammatory properties. , 1997, Biochemistry.

[38]  P. Jeffery,et al.  Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. , 1997, American journal of respiratory and critical care medicine.

[39]  J. G. Douglas,et al.  Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. , 1997, Thorax.

[40]  R. Strieter,et al.  Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. , 1996, American journal of respiratory and critical care medicine.

[41]  J. M. Cousin,et al.  Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. , 1996, Journal of immunology.

[42]  C. Gerard,et al.  Receptor binding specificity and pulmonary gene expression of the neutrophil-activating peptide ENA-78. , 1996, American journal of respiratory cell and molecular biology.

[43]  L. Fabbri,et al.  Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. , 1995, American journal of respiratory and critical care medicine.

[44]  A. Chuntharapai,et al.  Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor. , 1995, Journal of immunology.

[45]  M. Burdick,et al.  Stimulus and cell-specific expression of C-X-C and C-C chemokines by pulmonary stromal cell populations. , 1995, The American journal of physiology.

[46]  G. Cox,et al.  Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. , 1995, Journal of immunology.

[47]  Kwang Woo Kim,et al.  Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. , 1995, The Journal of allergy and clinical immunology.

[48]  M. Burdick,et al.  Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat. The role of epithelial neutrophil activating protein. , 1995, The Journal of clinical investigation.

[49]  L. Fabbri,et al.  Airway eosinophilia in chronic bronchitis during exacerbations. , 1994, American journal of respiratory and critical care medicine.

[50]  T. Standiford,et al.  Cytokines. 2. Cytokines and lung inflammation: mechanisms of neutrophil recruitment to the lung. , 1993, Thorax.

[51]  L. Fabbri,et al.  Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. , 1993, The American review of respiratory disease.

[52]  W. Wood,et al.  Characterization of two high affinity human interleukin-8 receptors. , 1992, The Journal of biological chemistry.

[53]  R. Strieter,et al.  Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8 , 1991, The Journal of experimental medicine.